Annual Operating Expenses
$18.87 M
+$3.60 M+23.57%
31 December 2023
Summary:
CNS Pharmaceuticals annual total operating expenses is currently $18.87 million, with the most recent change of +$3.60 million (+23.57%) on 31 December 2023. During the last 3 years, it has risen by +$9.41 million (+99.53%). CNSP annual operating expenses is now at all-time high.CNSP Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$5.63 M
+$3.10 M+122.65%
30 September 2024
Summary:
CNS Pharmaceuticals quarterly total operating expenses is currently $5.63 million, with the most recent change of +$3.10 million (+122.65%) on 30 September 2024. Over the past year, it has increased by +$1.10 million (+24.15%). CNSP quarterly operating expenses is now at all-time high.CNSP Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CNSP Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +23.6% | +24.1% |
| 3 y3 years | +99.5% | +47.6% |
| 5 y5 years | +2039.4% | +705.2% |
CNSP Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +99.5% | at high | +122.7% |
| 5 y | 5 years | at high | +2039.4% | at high | +705.2% |
| alltime | all time | at high | +2039.4% | at high | +3213.1% |
CNS Pharmaceuticals Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $5.63 M(+122.7%) |
| June 2024 | - | $2.53 M(-28.7%) |
| Mar 2024 | - | $3.54 M(-34.1%) |
| Dec 2023 | $18.87 M(+23.6%) | $5.38 M(+18.7%) |
| Sept 2023 | - | $4.53 M(+12.6%) |
| June 2023 | - | $4.03 M(-18.3%) |
| Mar 2023 | - | $4.93 M(-4.1%) |
| Dec 2022 | $15.27 M(+5.4%) | $5.13 M(+50.2%) |
| Sept 2022 | - | $3.42 M(-4.1%) |
| June 2022 | - | $3.56 M(+13.2%) |
| Mar 2022 | - | $3.15 M(-3.1%) |
| Dec 2021 | $14.49 M | $3.25 M(-14.7%) |
| Sept 2021 | - | $3.81 M(+0.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2021 | - | $3.81 M(+5.6%) |
| Mar 2021 | - | $3.61 M(+20.3%) |
| Dec 2020 | $9.45 M(+146.7%) | $3.00 M(+49.3%) |
| Sept 2020 | - | $2.01 M(-18.7%) |
| June 2020 | - | $2.47 M(+25.7%) |
| Mar 2020 | - | $1.97 M(-22.0%) |
| Dec 2019 | $3.83 M(+334.7%) | $2.52 M(+261.0%) |
| Sept 2019 | - | $699.10 K(+68.4%) |
| June 2019 | - | $415.10 K(+112.8%) |
| Mar 2019 | - | $195.10 K(-6.5%) |
| Dec 2018 | $881.80 K | $208.60 K(+22.8%) |
| Sept 2018 | - | $169.90 K(-13.6%) |
| June 2018 | - | $196.60 K |
FAQ
- What is CNS Pharmaceuticals annual total operating expenses?
- What is the all time high annual operating expenses for CNS Pharmaceuticals?
- What is CNS Pharmaceuticals annual operating expenses year-on-year change?
- What is CNS Pharmaceuticals quarterly total operating expenses?
- What is the all time high quarterly operating expenses for CNS Pharmaceuticals?
- What is CNS Pharmaceuticals quarterly operating expenses year-on-year change?
What is CNS Pharmaceuticals annual total operating expenses?
The current annual operating expenses of CNSP is $18.87 M
What is the all time high annual operating expenses for CNS Pharmaceuticals?
CNS Pharmaceuticals all-time high annual total operating expenses is $18.87 M
What is CNS Pharmaceuticals annual operating expenses year-on-year change?
Over the past year, CNSP annual total operating expenses has changed by +$3.60 M (+23.57%)
What is CNS Pharmaceuticals quarterly total operating expenses?
The current quarterly operating expenses of CNSP is $5.63 M
What is the all time high quarterly operating expenses for CNS Pharmaceuticals?
CNS Pharmaceuticals all-time high quarterly total operating expenses is $5.63 M
What is CNS Pharmaceuticals quarterly operating expenses year-on-year change?
Over the past year, CNSP quarterly total operating expenses has changed by +$1.10 M (+24.15%)